Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: A preliminary open-label trial

International Clinical Psychopharmacology

Volumn 23, Issue 4, 2008, Pages 228-231

  Golubchik, Pavel ^a,b   Sever, Jonathan ^a,b   Zalsman, Gil ^a,b   Weizman, Abraham ^a,b  

^a GEHA MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Adolescent; Attention deficit hyperactivity disorder; Borderline personality disorder; Methylphenidate

Indexed keywords

ATOMOXETINE; METHYLPHENIDATE; REBOXETINE; RISPERIDONE; CENTRAL STIMULANT AGENT;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; AGGRESSION; ANOREXIA; APPETITE DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BORDERLINE STATE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIZZINESS; DRUG EFFICACY; DRUG INDICATION; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; INSOMNIA; IRRITABILITY; OPEN STUDY; PRIORITY JOURNAL; RATING SCALE; SIDE EFFECT; STOMACH PAIN; SYMPTOMATOLOGY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BORDERLINE PERSONALITY DISORDER; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; HUMANS; METHYLPHENIDATE; PROSPECTIVE STUDIES;

EID: 54049092464     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/YIC.0b013e3282f94ae2     Document Type: Article

References (27)

1. American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders DSM-IV-TR, Fourth edition. Text revision. Washington, DC: American Psychiatric Association.
2. Aron AR, Dowson JH, Sahakian BJ, Robbins TW (2003). Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 54:1465-1468.
3. Barkley RA, Fischer M, Edelbrock CS, Smallish L (1990). The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. J Am Acad Child Adolesc Psych 29:546-557.
4. Cukrowicz KC, Taylor J, Schatschneider C, Iacono WG (2006). Personality differences in children and adolescents with attention-deficit/hyperactivity disorder, conduct disorder, and controls. J Child Psychol Psychiatry 47:151-159.
5. Davids E, Gastpar M (2005). Attention deficit hyperactivity disorder and borderline personality disorder. Prog Neuropsychopharmacol Biol Psychiatry 29:865-877.
6. Dowson JH, McLean A, Bazanis E, Toone B, Young S, Robbins TW, et al. (2004). The specificity of clinical characteristics in adult with attention/hyperactivity disorder: a comparison with patients with borderline personality disorder. Eur Psychiatry 19:72-78.
7. DuPaul GJ, Power TJ, Anastopoulos AD, Reid R (1998). ADHD Rating Scale-IV: checklist, norms, and clinical interpretation. New York: Guilford.
8. First MB, Spitzer RL, Gibbon M, Williams JBW, Benjamin L (1996). Structured clinical interview for DSM-IV Axis II personality disorders (SCID-II). Version 2.0. New York, NY: Biometrics Research Department, New York State Psychiatric Institute.
9. First MB, Spitzer RL, Gibbon M, Williams JBW (1997). Structured clinical interview for DSM-IV Axis I disorders-clinical version (SCID-CV). Washington, DC: American Psychiatric Press.
10. Fossati A, Novella L, Donati D, Donini M, Maffel C (2002). History of childhood attention deficit/hyperactivity disorder symptoms and borderline personality disorder: a controlled study. Compr Psychiatry 5:369-377.
11. Guy W (1976). ECDEU assessment manual for psychopharmacology. Rockville, MD: Psychopharmacology Research Branch, US National Institute of Health. pp. 217-222.
12. Helgeland MI, Kjelsberg E, Torgersen S (2005). Continuities between emotional and disruptive behavior disorders in adolescence and personality disorders in adulthood. Am J Psychiatry 162:1941-1947.
13. Hooberman D, Stern TA (1984). Treatment of attention deficit and borderline personality disorders with psychostimulants: case report. J Clin Psychiatry 45:441-442.
14. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, et al. (1997). Schedule for affective disorder and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988.
15. Lampe K, Konrad K, Kroener S, Fast K, Kunert HJ, Herpertz SC (2007). Neuropsychological and behavioural disinhibition in adult ADHD compared to borderline personality disorder. Psychol Med 37:1717-1729.
16. Lofgren DP, Bemporad J, King J, Lindem K, O'Driscoll GA (1991). A prospective follow-up study of so-called borderline children. Am J Psychiatry 148: 1541-1547.
17. Martin CA, Guenthner G, Bingcang C, Rayens MK, Kelly TH (2007). Measurement of the subjective effects of methylphenidate in 11- to 15-year-old children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 17:63-73.
18. Orvaschel H (1985). Psychiatric interviews suitable for use in research with children and adolescents. Psychopharmacol Bull 21:737-745.
19. Philipsen A (2006). Differential diagnosis and comorbidity of attention-deficit/hyperactivity disorder (ADHD) and borderline personality disorder (BPD) in adults. Eur Arch Psychiatry Clin Neurosci 256 (Suppl 1):i42-i46.
20. Post RM, Chang KD, Findling RL, Geller B, Kowatch RA, Kutcher SP, et al. (2004). Prepubertal bipolar I disorder and bipolar disorder NOS are separable from ADHD. J Clin Psychiatry 65:898-902.
21. Rey JM, Morris-Yates A, Singh M, Andrews G, Stewart GW (1995). Continuities between psychiatric disorders in adolescents and personality disorders in young adults. Am J Psychiatry 152:895-900.
22. Ross RG (2006). Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder. Am J Psychiatry 163:1149-1152.
23. Schulz SC, Cornelius J, Schulz PM, Soloff PH (1988). The amphetamine challenge test in patients with borderline disorder. Am J Psychiatry 145: 809-814.
24. Spencer T, Biederman J, Wilens T (1999). Attention-deficit/hyperactivity disorder and comorbidity. Pediatr Clin North Am 46:915-927.
25. Van Reekum R, Links PS (1994). N of 1 study: methylphenidate in a patient with borderline personality disorder and attention deficit hyperactivity disorder. Can J Psychiatry 39:186-187.
26. Ward MF, Wender PH, Reimherr FW (1993). The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 150:885-890.
27. Wilson ST, Stanley B, Oquendo MA, Goldberg P, Zalsman G, Mann JJ (2007). Comparing impulsiveness, hostility, and depression in borderline personality disorder and bipolar II disorder. J Clin Psychiatry 68:1533-1539.